Abstract: Marine sulfated polysaccharides (MSP), such as sulfated fucans (SF), sulfated galactans (SG) and glycosaminoglycans (GAG) isolated from either algae or invertebrate animals, are highly anionic polysaccharides capable of interacting with certain cationic proteins, such as (co)-factors of the coagulation cascade during clotting-inhibition processes. These molecular complexes between MSP and coagulation-related proteins might, at first glance, be assumed to be driven mostly by electrostatic interactions. However, a systematic comparison using several novel sulfated polysaccharides composed of repetitive oligosaccharides with clear sulfation patterns has shown that these molecular interactions are regulated essentially by the stereochemistry of the glycans (which depends on a conjunction of anomericity, monosaccharide, conformational preference, and glycosylation and sulfation sites), rather than just a simple consequence of their negative charge density (mainly the number of sulfate groups). Here, we present an overview of the structure-function relationships of MSP, correlating their structures with their potential anticoagulant and antithrombotic actions, since pathologies related to the cardiovascular system are one of the major causes of illness and mortality in the world.
Introduction

The trends for regular chemical structures in invertebrates and red algae
The efforts in both structural and functional studies of marine sulfated polysaccharides (MSP) have been increasing signifi cantly over the last ten years (Pomin, 2008; Pomin & Mourão, 2008) . This attention is a consequence of the great interest in novel sulfated polysaccharides (SP) such as glycosaminoglycans (GAG) . GAG are of particular interest to researchers looking for alternative and/or safer sources of heparin . Heparin has been the most clinically exploited anticoagulant over the last 50 years (Fareed et al., 2000) . Until the early 90's, sulfated fucans (SF), homopolymers of fucopyranosyl units exclusively in the α-L-form (Pomin, 2008; Pomin & Mourão, 2008) , and sulfated galactans (SG), homopolymers of α-L-or α-Dand/or β-D-galactopyranosyl units (Pomin, 2009) , were usually extracted and characterized from the cell walls of the three major groups of macroalgae. Phaeophyta (brown algae) expresses SF, while Rhodophyta (red algae) and Chlorophyta (green algae) both express SG.
Historically, algal SF and SG are used mainly in clinical tests and large-scale extractions for industrial purposes. Recently, however, new and interesting sources of these compounds have been found in the extracellular matrices of certain marine invertebrates Mourão, 2004; 2007; Pomin, 2008; 2009; Pomin & Mourão, 2008) . In contrast with most algal sulfated polysaccharides, the invertebrate polymers exhibit highly regular chemical structures ( Figure 1 and 2A-D), which make it easier to correlate their biological functions with their respective structural features (Pomin, 2008; Pomin & Mourão, 2008; Vilela-Silva et al., 2008) . This is of enormous benefi t to the entire fi eld of glycobiology. At one time, it was relatively hard to develop accurate structure-activity relationships for the majority of SPs. This same advantage is also observed for some marine invertebrate GAG ( Figure 2F ). In contrast, many mammalian GAG exhibit a large variety of sulfation patterns (Gandhi & Mancera, 2008) and, consequently, demand much more effort to assay their biological activities, determine their specifi c structural features and subsequently propose a dependable structure-function relationship.
The MSP with well-defi ned chemical structures (SF, SG and GAG in Figures 1 and 2 ) are extracted from echinoderms (Echinodermata) like sea cucumbers (Mulloy et al., 2004) ; (B) Lytechinus variegatus (Alves et al., 1997) ; (E) Strongylocentrotus purpuratus-I (Stimpson, 1857) (Alves et al., 1998) Vilela-Silva et al., 2002) ; and (H) Strongylocentrotus franciscanus (A. Agassiz, 1863) Vilela-Silva et al., 1999) . (Castro et al., 2009) (Santos et al., 1992) (Mourão & Perlin, 1987) ; (E) both Botryocladia occidentalis (Kylin, 1931) and Gelidium crinale (Gaillon 1828) express [3-β-D-Galp-1→4-α-Gal-1→] n with different sulfation contents (Pereira et al., 2005; Fonseca et al., 2008) ; and (F) the DS from Styela plicata, Halocynthia pyriformis (Rathke, 1806), and Ascidian nigra (Savigny, 1816) are composed of [4-α-L-IdoA-1→3-β-D-GalNAc-1] n with also different sulfation patterns (Pavão et al., 1995; Pavão et al., 1998) . H. pyriformis 70 <5 99 1
(Holothuroidea) (Mulloy et al. 2004 ) and sea urchins (Echinoidea) (Pomin & Mourão, 2008; Vilela-Silva et al., 2008) or ascidians (Urochordata, Ascidiacea) (Mourão & Perlin, 1987; Santos et al., 1992; Pavão et al., 1995; Pavão et al., 1998; Vicente et al., 2001; Pavão, 2002) . The SF ( sea urchin eggs. As discussed below, these particular MSP are physiologically responsible for controlling the external fertilization in sea urchins in a very restrictive species-specific manner (Mourão, 2007; Vilela-Silva et al., 2008) . Among all the MSP with well-defined chemical structures described so far (Figures 1 and 2 ), there is a single description from the body wall of the sea cucumber ( Figure 1A ) (Mulloy et al., 2004 ), a few examples of SG isolated from the tunic of ascidians ( Figure 2C and 2D) (Mourão & Perlin, 1987; Santos et al., 1992; Pavão et al., 1998) , and some reports from specific red algal cell walls ( Figure 2E ) (Pereira et al., 2005; Fonseca et al., 2008) . All of the remaining structures ( Figure 1B -H and 2A and B) belong to the egg jelly coat of sea urchins (Alves et al., 1997; Alves et al., 1998; Vilela-Silva, et al., 1999; Vilela-Silva et al., 2002; Mulloy et al., 2004) The body of some species of ascidians also contains peculiar GAG that show sulfation patterns distinct from mammalian GAG (Pavão et al., 1995; Pavão et al., 1998) , as exemplified by the tunicate dermatan sulfates (DS) in Figure 2F .
The interaction of MSPs with coagulation (co)-factors: stopping blood coagulation
Unrelated to their natural biological role as inducers of fertilization, the SF and SG also exhibit potential pharmacological actions in mammalian systems. Among several clinical activities such as antiviral, antimetastatic, anti-angiogenic, anti-inflammatory, and anti-adhesive (Coombe et al., 1987; Harrop et al., 1992; Cumashi et al., 2007) , the anticoagulant and antithrombotic actions are the most explored so far (Farias et al., 2000; Pomin, 2008) . This is due to a pressing need for new antithrombotic drugs as a consequence of the increasing incidence of thromboembolic diseases. In fact, cardiovascular diseases are the leading cause of death worldwide (30% of total causes) Pereira et al., 1999; Farias et al., 2000; Pereira et al., 2002a,b; Berteau & Mulloy, 2003; Mourão, 2004; Pereira et al., 2005; Becker et al., 2007; Cumashi et al., 2007; Pomin, 2008; 2009; Pomin & Mourão, 2008) .
The SF and SG show great advantages as alternative sources for anticoagulant therapies, especially because of the massive use of heparin (Fareed et al., 2000) . This mammalian GAG has the highest negative charge density ever found in a natural molecule. It is also well known to present several limitations due to collateral effects and limited sources of material (Mourão, 2004) . The situation has been complicated recently due to the alarming discovery of heparin preparations that have been contaminated with oversulfated chondroitin sulfate (Guerrini et al., 2008) . This contaminant induces hypotension associated with kallikrein release when administered by intravenous injection (Kishimoto et al., 2008) . Fatal cases have been described.
The new MSP (Figures 1 and 2) offer some advantages over heparin. They show considerably lower contamination levels of virus and/or prions because they are exclusively extracted from marine sources. Contamination in clinical solutions of heparin can occur more easily since this compound is extracted from mammalian sources, like porcine and bovine intestinal mucosa and bovine lung (Mourão, 2004) . Moreover, the invertebrate MSP have the potential of being more useful as clinical reagents than algal SP due to their regular and well-defined structures (Mourão, 2004; Pomin, 2008; Pomin & Mourão, 2008) , even though algal molecules have been utilized more until now.
In addition to all the benefits described above, the very clear and regular structures of invertebrate SF (Figure 1 ) and SG (Figure 2A-D) , the algal SG ( Figure 2E ) and the ascidian GAG ( Figure 2F ) enable determination of well-defined structure-function relationships (Pomin, 2008; Pomin & Mourão, 2008) . This knowledge allows prediction of the major molecular features involved in molecular interactions such as those between the MSP and blood (co)factors, similar to the use in the fertilization assays mentioned in the previous section. The anticoagulant action of the SP resides mainly in the potentiation of natural inhibitors of plasma proteases. The plasma proteases include activated factor II (IIa, commonly known as thrombin) and activated factor X (Xa). Inhibitors include the serpins (antithrombin, AT; and heparin cofactor II, HCII). The catalysis of SP can be classified into two distinct mechanisms: (i) the allosteric change of the serpins induced by the SP; and (ii) the template mechanisms, where the glysidic chain of the SP can act as a ''bridge'' that brings together both protease and serpin. The mechanisms for AT and HCII are illustrated in Figures 3A and 3B , respectively.
Next we will describe particular cases of how each specific structural feature of the MSP (Figures  1 and 2) can individually account for different levels of activity and interaction with serpins and/or blood proteases (Figure 3 ). This results in differing kinetics of preventing clot formation. The particular structural contributions of the MSP can be properly recognized when the anticoagulant properties of these biopolymers are systematically compared. In addition, the results might offer qualitatively accurate data. This systematic comparison was carried out by two in vitro anticoagulant assays: (i) the aPTT (activated partial thromboplastin time), which measures the general anticoagulant effect when all the plasma proteins are included, and (ii) the direct measurement of the inhibition level of factors IIa or Xa by AT or HCII in the presence of the MSP. Results from these assays are compiled in Table 1 .
Influential structural features of MSP in interactions with coagulation (co)-factors
Monosaccharide type-dependent case
Comparing all the structures in Figures 1  and 2 , one can discern structural similarities and differences in the SF and SG. For example, both SF from Strongylocentrotus franciscanus ( Figure 1H ), and SG from Echinometra lucunter (Figure 2A ) present the same sulfation pattern (exclusive and entirely 2-sulfated), the same anomeric configuration (α-form), the same glycosidic linkage (1→3) and the same molecular mass (~100 kDa). Their single difference is their sugar type (fucopyranose or galactopyranose, respectively) (Pomin, 2008) . Interestingly, this single structural difference is itself enough to promote great changes in the anticoagulant properties of these homopolysaccharides. The 2-sulfated α-galactan from E. lucunter exhibits a significant anticoagulant activity (aPTT of 20 IU mg, although almost 10-fold less than UFH, Table 1 ). The specific anticoagulant assay with the purified proteases revealed that this SG enhances both IIa and factor Xa inhibition by either AT or HCII (Table 1) . On the other hand, the anticoagulant effect of 2-sulfated α-fucan from S. franciscanus is exclusively based on catalysis of AT inhibition over factor Xa, although it is 12.5-fold less active than the α-SG. This single effect on the Xa/AT system explains the much lower activity of the compound from S. franciscanus (aPTT of ~2 IU mg -1 , 100-fold less active than UFH) since the anti-Xa activity has a relatively minor influence on the aPTT. This is an illustrative and typical example of a sugar-type-dependent biological effect of polysaccharides.
Preferential conformation binding-dependent case
Interaction energies obtained from molecular dynamics (MD) simulations are statistically equivalent for both the 2-sulfated α-L-galactan from E. lucunter (Figure 2A ) and the 2-sulfated α-L-fucan from S. franciscanus ( Figure 1H ). This would be expected based on the structural similarities of these two compounds, especially their conformations in solution. However, they revealed markedly different interactions for binding with the complex AT/IIa. The explanation for this result is the extreme difference in orientation on the AT binding site (~90 o , Figures 4C and 4D ). Such a difference in orientation upon binding to AT explains the lack of activity of SF under the same experimental conditions . In both cases, the SP (gray line) brings together the serpins and protease-IIa mainly through electrostatic interactions of their opposite charges. In the thrombin, this charged cluster is the EXO II. Next, the hydroxyl groups of a serine (S) residue from thrombin will bind to the C-terminus of the serpins, actually to an arginine (R) residue of the AT (A), or to a lysine (K) residue in the case of HC-II (B). In the bound-states, a conformational change occurs in both serpins, although this change is more predominant and necessary in the HC-II case. (B) Note that the N-terminus of HC-II also interacts with the EXO I of IIa, also through electrostatic contacts. With the examples described throughout the text, it is clear that the template mechanisms between SP (SF, SG, GAG), serpins (AT, HC-II) and protease (IIa) have differential stabilities or formation kinetics that are directly related to the structural features of the SP. and fully supports the expected bridging mechanism for the activity of SG, as previously described (Melo et al., 2004) . Thus, both compounds are capable of interacting with AT, as indicated by theoretical results and experimental data showing that both polysaccharides are retained on an AT-affinity column. However, only the complex formed by SG and AT ( Figure 4D ) allows further interaction with IIa. An analogous complex is the ternary (Pavão et al., 1998; Mourão, 2004; Pereira et al., 2005; Fonseca et al., 2008 Pavão et al., 1998. complex between heparin-AT-IIa ( Figure 4A ), which supports the potentiation of this protease inactivation by AT in the presence of SG. This is an example of how the orientational constraints in solution can influence spatial preferences of the SP for their different bindings with target proteins (Melo et al., 2004) . It is obvious that the difference in the sugar type drastically changes the conformation of the polymer as well, implying a different conformational binding, as explained in this section.
Sulfation pattern-dependent case
Based on this same systematic comparison, the SG from the red algal species Botryocladia occidentalis and Gelidium crinale exhibit identical backbones and the same chain size. However, there are slight differences in their sulfation patterns ( Figure 2E ). As a consequence of this difference, the two algal SG differ in their anticoagulant and venous antithrombotic activities, as previously described (Fonseca et al., 2008) . SG from G. crinale exhibit pro-coagulant and pro-thrombotic effects in low doses (up to 1.0 mg/kg body weight). At high doses (>1.0 mg/kg), this polysaccharide inhibits both venous and arterial thrombosis in rats. In contrast, SG from B. occidentalis is a very potent anticoagulant and antithrombotic compound in low doses (up to 0.5 mg/kg body weight), inhibiting experimental venous thrombosis, but these effects are reverted at high doses. Conversely, arterial thrombosis is only inhibited at high doses (>1.0 mg/kg) of the polysaccharide from B. occidentalis. These results indicate that slight differences in the proportions and/or distribution of sulfated residues along the galactosyl chain may be critical for the interaction between proteases, inhibitors, and activators of the coagulation system, resulting in a distinct pattern in the anti-and pro-coagulant activities and in the antithrombotic action. As summarized in Table 1 , these structural differences account for the 30% difference in anticoagulant activity (aPTT) of these algal macromolecules and the even greater difference in catalytic effect of the sulfated polysaccharide on HCII-mediated anti-IIA activity.
Indeed, the structural requirements for the interaction of these SP with the coagulation cofactors and their target proteases and inhibitors are stereospecific Mourão, 2004; Pomin, 2008; Pomin & Mourão, 2008) . The site of sulfation has a major impact on activity. This can be illustrated by the fact that 2,4-di-sulfated units have an amplifying effect on the AT-mediated anticoagulant activity in the series of 3-linked α-L-fucans (Figure 1, Table 1 ). Specific sulfation sites are required for the interaction with plasma serineprotease inhibitors. Note the occurrence of the 4-sulfated unit content in the 3-linked α-L-fucans: L. variegatus (a single 4-sulfated unit/tetrasaccharide - Figure 1B) , S. pallidus (a double 4-sulfated unit/tetrasaccharide - Figure  1C) , and S. purpuratus, isotype II (a double 4-sulfated unit/trisaccharide - Figure 1F ). This 4-sulfation is the structural motif required to enhance the inhibition of IIa by HCII. In contrast, the presence of 2-sulfated residues seems to have a deleterious effect on HCII-mediated anti-IIA activity of the polysaccharides (Mourão, 2004) .
Ascidian DS with the backbone structure [4-α-L-IdoA-1→3-β-D-GalNAc-1] n but with different patterns of sulfation ( Figure 2F ) also reveal different anticoagulant activities (Table 1) (Pavão et al., 1995; Pavão et al., 1998; Vicente et al., 2001) . They are also useful and reliable cases to describe the influence of sulfation sites on biological actions. All three ascidian DSs have a high content of 2-O-sulfated α-L-iduronic acid residues, but differ in the pattern of sulfation of the N-acetyl-β-D-galactosaminyl units. Styela plicata and Halocynthia pyriformis have 4-O-sulfated units, but in Ascidian nigra they are 6-Osulfated. This collection of ascidian DS, where the extent and position of sulfate substitution have been well characterized, was examined in anticoagulant assays. DS from A. nigra has no discernible anticoagulant activity, which indicates that 4-O-sulfation of the N-acetyl-β-Dgalactosamine is essential for that activity (Table 1) . In contrast, DS from S. plicata and H. pyriformis are potent anticoagulants due to potentiation of thrombin inhibition by HC-II. These ascidian DS have ~10-fold and ~6-fold higher activity with HC-II than native and oversulfated mammalian DS respectively (Table 1) . They have no effect on factor IIa-or Xa-inhibition by AT. These highly sulfated ascidian DS show that they require very selective sulfation sites to promote the HC-II interactions and, consequently, their highly specific anticoagulant properties are intimately related to their sulfation levels (Table 1 vs. Figure 2F ).
Concluding remarks
The examples cited in this work clearly show how the structural features of marine homopolysaccharides (sulfated fucans and galactans) can be used to evaluate interactions with coagulation proteins (acting as promising anticoagulant or antithrombotic reagents). It was observed that the carbohydrate-protein complexes are indeed stereospecific and not a mere consequence of charge density. It is important to note that the glycosidic structural characteristics examined individually in the sections above do not really account independently and/or exclusively for the biological actions or molecular interactions. Obviously the active or inactive conformations of these homopolysaccharides arise from the presence of all structural features acting together, which comprise the ''final code'' required for high-affinity interactions with the target proteins. However, specific or major structural features of the carbohydrates certainly act as preponderant regulators of biological functions, as succinctly described in this work.
